TrialEuropean journal of immunology2020
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.
Patrícia Figueiredo-Campos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
131 papers cite itlatest 60 shown
this paperpooled ittrialcites it